Bandaram Pharma Packtech (BSE 524602)₹19.14+3.29%Healthcare Service Provider
In the Sep 2026 quarter (consolidated), Bandaram Pharma Packtech reported sales of ₹21.52 Cr, up 56.4% from Sep 2025, and net profit of ₹0.18 Cr, up 260.0% year on year. For the year to Mar 2026, sales were ₹63.11 Cr and net profit ₹0.27 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.39 | 13.46 | 11.40 | 7.13 | 10.04 | 8.51 | 8.13 | 13.76 | 14.89 | 26.34 | 24.04 | 21.52 |
| Expenses | 6.92 | 12.76 | 10.87 | 6.04 | 9.38 | 7.98 | 7.49 | 13.33 | 13.89 | 25.55 | 22.49 | 20.35 |
| Operating Profit | 0.46 | 0.72 | 0.53 | 1.08 | 0.65 | 0.53 | 0.62 | 0.44 | 0.99 | 0.81 | 1.54 | 1.15 |
| OPM % | 6.4% | 5.5% | 4.8% | 15.4% | 6.6% | 6.4% | 7.8% | 3.3% | 6.8% | 3.1% | 6.5% | 5.4% |
| Other Income | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest | 0.16 | 0.31 | 0.20 | 0.25 | 0.23 | −0.09 | 0.45 | 0.24 | 0.32 | 0.45 | 0.41 | 0.47 |
| Depreciation | 0.19 | 0.20 | 0.16 | 0.16 | 0.16 | 0.54 | 0.14 | 0.15 | 0.15 | 0.26 | 0.21 | 0.26 |
| Profit before tax | 0.13 | 0.26 | 0.19 | 0.69 | 0.28 | 0.21 | 0.05 | 0.08 | 0.54 | 0.13 | 0.94 | 0.44 |
| Tax % | 0.0% | 24.1% | 0.0% | 0.0% | 103.8% | 25.1% | 25.1% | 28.6% | 34.0% | 25.1% | 25.9% | 55.9% |
| Net Profit | 0.11 | 0.18 | 0.17 | 0.66 | −0.01 | 0.14 | 0.01 | 0.05 | 0.34 | 0.08 | 0.68 | 0.18 |
| EPS (Rs) | 0.09 | 0.15 | 0.14 | 0.55 | 0.00 | 0.11 | 0.01 | 0.03 | 0.12 | 0.04 | 0.12 | −0.13 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 0.00 | 18.80 | 34.16 | 37.05 | 63.11 | 86.79 |
| Expenses | 0.02 | 17.65 | 31.40 | 34.25 | 60.26 | 82.28 |
| Operating Profit | 0.00 | 1.14 | 2.81 | 2.82 | 2.90 | 4.49 |
| OPM % | — | 6.2% | 8.3% | 7.7% | 4.6% | 5.2% |
| Other Income | 0.00 | 0.20 | 0.04 | 0.10 | 0.03 | 0.02 |
| Interest | 0.00 | 0.42 | 0.92 | 0.98 | 1.50 | 1.65 |
| Depreciation | 0.00 | 0.60 | 0.74 | 0.62 | 0.98 | 0.88 |
| Profit before tax | −0.02 | 0.33 | 1.20 | 1.33 | 0.46 | 2.05 |
| Tax % | 0.0% | 21.9% | 20.2% | 24.3% | 35.6% | — |
| Net Profit | 0.00 | 0.25 | 0.94 | 0.98 | 0.27 | 1.28 |
| EPS (Rs) | 0.00 | 0.11 | 0.78 | 0.81 | 0.15 | 0.15 |
| Dividend payout % | 0.0% | 21.4% | 12.6% | 12.1% | 0.0% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 7.06 | 3.01 | 12.02 | 12.02 | 17.99 |
| Reserves | −0.05 | 0.07 | 0.27 | 0.64 | 8.79 |
| Borrowings | 0.00 | 14.20 | 12.21 | 17.16 | 23.94 |
| Other Liabilities | 0.48 | 2.92 | 7.59 | 9.11 | 25.17 |
| Total Liabilities | 7.49 | 20.20 | 32.09 | 38.93 | 75.89 |
| Fixed Assets | 2.88 | 5.04 | 4.49 | 3.96 | 15.26 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.10 | 0.00 | 1.41 | 1.41 | 0.00 |
| Other Assets | 2.51 | 15.16 | 26.19 | 33.56 | 60.63 |
| Inventories | 0.08 | 2.72 | 6.48 | 8.52 | 12.96 |
| Trade receivables | 0.00 | 6.64 | 14.57 | 18.83 | 31.45 |
| Cash & equivalents | 0.05 | 0.15 | 0.05 | 0.13 | 0.71 |
| Total Assets | 7.49 | 20.20 | 32.09 | 38.93 | 75.89 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | −1.11 | −4.14 | −4.94 | −4.93 |
| Cash from investing activity | −5.31 | −1.59 | −0.09 | 0.00 |
| Cash from financing activity | 4.46 | 5.58 | 5.08 | 5.52 |
| Net cash flow | −1.94 | −0.12 | 0.09 | 0.61 |
| Capex | 2.78 | 0.17 | 0.09 | 0.00 |
| Free cash flow | −3.90 | −4.32 | −5.02 | −4.93 |
| CFO / OP % | −96.0% | −139.0% | −163.0% | −168.9% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 129 | 156 | 185 | 182 |
| Cash conversion cycle | 129 | 156 | 185 | 182 |
| Working capital days | 148 | 149 | 166 | 128 |
| ROCE % | 5.7% | 9.2% | 7.7% | 4.5% |
For the Sep 2026 quarter, Bandaram Pharma Packtech reported sales of ₹21.52 Cr, up 56.4% year on year and net profit of ₹0.18 Cr, up 260.0% year on year. The operating margin was 5.4%.
Bandaram Pharma Packtech's sales for the year to Mar 2026 were ₹63.11 Cr; over the last twelve months they were ₹86.79 Cr.
Net profit for the year to Mar 2026 was ₹0.27 Cr, and ₹1.28 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.15.
Bandaram Pharma Packtech reported borrowings of ₹23.94 Cr at Mar 2026, against cash and equivalents of ₹0.71 Cr.
Cash from operations was −₹4.93 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹4.93 Cr.